Immunovant, Inc. IMVT CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s capex?
- Immunovant, Inc. (IMVT) reported capex of $8K in Q1 2026.
- How has Immunovant, Inc.'s capex changed year-over-year?
- Immunovant, Inc.'s capex decreased by 96.0% year-over-year, from $201K to $8K.
- What is the long-term trend for Immunovant, Inc.'s capex?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s capex has grown at a -57.9% compound annual growth rate (CAGR), from $254K to $8K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.